Tenaya Therapeutics Inc [TNYA] stock is trading at $2.41, up 24.23%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TNYA shares have gain 15.87% over the last week, with a monthly amount glided 36.16%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Leerink Partners started tracking the stock with Outperform rating on November 30, 2023, and set its price target to $7. On June 15, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $25 on the stock.
Tenaya Therapeutics Inc [TNYA] stock has fluctuated between $1.61 and $7.01 over the past year. Tenaya Therapeutics Inc [NASDAQ: TNYA] shares were valued at $2.41 at the most recent close of the market.
Analyzing the TNYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at -7.19%, Pretax Profit Margin comes in at -6.84%, and Net Profit Margin reading is -6.84%. To continue investigating profitability, this company’s Return on Assets is posted at -0.74, Equity is -0.81 and Total Capital is -0.87. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.1400 points at the first support level, and at 1.8600 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.7200, and for the 2nd resistance point, it is at 3.0200.
Ratios To Look Out For
For context, Tenaya Therapeutics Inc’s Current Ratio is 6.28. In addition, the Quick Ratio stands at 6.28 and the Cash Ratio stands at 3.48.
Transactions by insiders
Recent insider trading involved Saito Chihiro, SVP, Accounting and Fin. Ops., that happened on Aug 16 ’24 when 2363.0 shares were sold. Chief Medical Officer, Tingley Whittemore completed a deal on Aug 16 ’24 to sell 7428.0 shares. Meanwhile, Chief Executive Officer Ali Faraz sold 9748.0 shares on Aug 16 ’24.
